by the end of accounting period (as of December 31, 2018 and 2017). - Other income from gain arising from change in fair value of biological assets which increased by amount of Baht 12 million

, which has been presented under loss from change in fair value of financial assets measured at fair value through profit and loss (Q2/2019 loss from exchange rate Baht 4 million) Profit / (Loss) For Q2

profit totaled to Baht 17 million including gain from change in fair value of financial assets of Baht 3 million, which is an increase of Baht 84 million (125%) from Q1/2019’s net loss of Baht 67 million

for expected credit losses and the fair value adjustments through profit or loss on additional financial assets in Q3-2022 -5- Liabilities Items that has significant changes Balance by Quarter Change Q3

contracts from the differences in fair value of the derivatives. Other income Q3-2019 Q2-2020 Q3-2020 9M-2019 9M-2020 Change THB Mn THB Mn THB Mn %QoQ %YoY THB Mn THB Mn %YoY Other income 1.8 0.9 3.0 233.3

, compared to the same period of the previous year had amount of Baht 7 million, increased by amount of Baht 14 million. 3. Other incomes from gain arising from change in fair value of biological assets which

and recognized gain or loss on forward contracts from the differences in fair value of the derivatives. Other income Q2-2019 Q1-2020 Q2-2020 6M-2019 6M-2020 Change THB Mn THB Mn THB Mn %QoQ %YoY THB Mn

by 20.8%. This represent net profit margin of 0.91%. The major reasons for the Company’s net profit increasing were the Company can achieve a higher total revenues and gain from fair value adjustment

%. The major reasons for the Company’s net profit increasing were the Company can achieve a higher total revenues and gain from fair value adjustment on investment property. Thus, the details of the

purchasing power. Performance Analysis Unit : MB For the period ended 31 March 2018 31 March 2017 Change MB % Net sales 261.84 255.90 5.94 2.32 Other income 13.06 10.57 2.49 23.56 Total revenues 274.90 266.47